Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-09-27

FDA Approved: VECTIBIX — Original Application (Amgen, Inc)

View source ↗

Summary

FDA approved VECTIBIX (panitumumab) in its original application for the treatment of metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vectibix (panitumumab)

Snippet

ORIG AP for VECTIBIX (PANITUMUMAB)